0	n/a
99	HeLa
107	Hela
200	HT-1080
292	kidney
308	HepG2
477	MN-1112
560	IMR-90
1299	HeLa S3
1322	KG-1
1330	A549
1338	HL-60
1386	HeLa 229 cells
1483	MRK-nu-1
1516	embryonic carcinoma NCR-G3
1537	WEHI-38
1613	SK-N-SH
1759	KE-4
1904	lymphoblastoid
1914	ME-1
1947	U937
1956	MKN28
2069	NCR-G3
2151	HUT102
2233	MCF-7
2983	primary culture
3048	KYSE410
3274	NUGC-3
3295	CaSki
3398	KSE-1
3415	Caco-2
4221	CMK86
4265	K562
4396	adenocarcinoma COLO 205
4509	UT-7
4539	TAPC301-CL4
4655	PAN07JCK
4725	KT-3
4756	NT2
5392	UT-M1
5469	Molt4
5474	Jurkat
5646	Molt-4 clone no.8
5669	G-361
5703	KB
5741	human gastric cancer cell line MKN-74
5760	bulk
5769	NALM6
5985	LAK cell
6007	HEK293
6076	HL-60 cells
6086	primary
6177	MDA-MB453
6205	HeLa cell
6212	jurkat
6272	293 cells
6284	RA-treated HL-60
6312	teratocarcinoma PA-1
7111	JHH7
7130	erythroleukemia cell
7241	Hela cell
7255	Jurkat cells
7388	Lymphoma Raji cell
7403	Colo 205
8100	KE4
8455	Y79
8539	MG63
8549	HeLa RCB0007
8565	THP-1
8592	COLO 205
8717	SK-MEL-37
9388	SW480
9625	HSC-45M2
9663	Jurkat cell
9725	primary-peripheral blood granulocytes
9791	KOCL-33
9800	HT1376
9892	teratocarcinoma; PA-1
10009	T-LAK cell
10171	Ntera-2 RA
10202	CHP134
10835	non-small cell lung cancer cell line, Ma29
11020	Human squamous carcinoma cell line
11134	U-2 OS
11206	HuS-L12
11289	PC-3
11306	Hep G2
11469	Jurkat, HeLa
12661	ACHN/CDDP
12670	HUT 78
12692	MKN45
12863	Daudi
12906	human promyelocytic leukemia cell line HL-60
13117	SCC-4
15024	CMK cell
15112	CMK
15185	HCS-2/8
15194	HPLF
15220	F36P
15228	HEK 293
15243	Molt-4, T98G
15256	U373MG
16035	GLC-82
16043	T24
16054	WI-38
16065	interferon-gamma stimulated U937 cell line
16082	B cell line
16131	Ewing's sarcoma
16194	MDA-MB-231 breast cancer cells
16207	pre-B leukaemia cell line G2
16340	M426
16367	Hs68
16551	HUT78 T-cell leukemia
16763	UCLA-162
16785	KB-V1
16877	SK-1
16921	huvec; HS913T
16954	Epstein-Barr virus-transformed B cells
16989	T-47D
17078	leukemia U937
17095	SiSo
17147	Burkitt lymphoma cell line
17208	HO-1
17364	breast adenocarcinoma MCF7
17431	293
17456	MDA-MB-231
17461	MCF7; estrogen receptor-expressing
17468	LOX
17485	LNCaP
17533	KCNR
17549	HTLV-1 transformed T cell line, HAT109
17567	human-human hybridoma B9165
17578	CEM
17660	CB23 B lymphoblastoid
17674	MDA-MB-175
17895	ZR75-1
17921	EBV transformed lymphoblastoid
18015	acute myleoid leukemia (AML-M2) cell line
18129	DLD-1; colon cancer cell line
18248	NbHOT
18254	BT474
18261	NCI H69
18605	HaCaT
18774	IL-2 dependent polyclonal NK
18832	KG-1a; KG-1
18976	TF-1
19159	NCIH292
19246	Ntera-2/RA
19328	Ntera-2
19359	HCC II
19376	EnCa-MZ-3
19416	MES-SA/DxP
19472	NCI-H146
19479	MCF-7 and 5Y neuroblastoma cells
19545	EBV-transformed B-cell line KT
19551	EBV-transformed B-cell line CH
19665	MCF7
19890	B-cell
19952	HEL
20227	Jurkat T cell
20600	premyeloid cell line TF-1
20608	chemosensitive PA-1 cells; Wu,G.S. Nat. Med.
20681	MDA-MB-435
20708	lymphoblastoid JY1 cells
20871	76N
20969	HT1080
21182	Mieliki
21310	C3-A11N; Nalm-6
21329	HIMeg
21361	squamous carcinoma L-78
21519	pancreatic cancer Patu 8988t
21527	Patu 8988t
21580	HL60 and 293
21689	HeLa cells
21696	HBL-100
21708	immortalized first trimester trophoblast cells
21953	MDA-468
22057	HL60
22075	pancreatic adenocarcinoma
22140	lung type-I cell
22168	NCI-H82
22189	NCI H82; NCI H345
22221	T47D
22283	HAT109
22299	NCI H82
22344	KT3
22418	EBV transformed human B-cell line fused to
22623	HeLa S3; ATCC CCL2.2
22795	Mo7p210
22802	Hs578T
23147	Jurkat T-cell
23512	Jurkat T cells
23538	neuroblastoma SH-SY-5Y
23620	THP-1; phorbol ester-treated 4 days
23664	TIL
23859	HeLa-S3
23863	promyelocytic leukemia HL-60 cell line
24033	NB4
24677	BT-20
24838	D98-H2 HeLa
24851	MOLT-4
24881	neuroblastoma 4s
24900	HL-60 promyelocytic cell-line
24983	K-562
25080	3D5
25821	Jurkat cell line RPMI 1640
25855	endometrial adenocarcinoma cell line HEC1B
25944	KG1
25982	CHRF-288-11
26644	Epstein-Barr Virus transformed B cell
26777	HeLA S3
26793	JEG-3 choriocarcinoma
26861	HA1
26938	HTR-8/SVneo
27096	Caco2
27186	Caco 2
27741	monoclonal cell line Ha5C2.A2
27747	GM10618
27752	GM10354
27759	HPB-ALL
28072	U2OS
28191	NT2 neuronal precursor
28220	T84; CaCo-2; HT29
28312	MT2
28690	HOS8603
28697	8226; H929
28708	MM96
28900	ZR-75
29115	JAR
29150	AsPC-1
29300	UVB-treated HaCaT
29305	U937; ATCCCRL-1593
29312	HeLa S2
29405	LNCaP; C4-2
29432	F240
29462	CCL-156
29755	UOC-B1
29884	MDA-MB
29939	CaCo2
30938	Mueller
31006	Daudi; HeLa
31295	293T
31332	myelin basic protein-specific T-cell line
31554	promyelocytic leukemia HL-60
32120	HaCaT; TF-1
32144	leukemia TF-1
32168	MCF10A
32174	HT29
32365	LS180
32375	WiDr
32508	HUVEC
32588	monoclonal cell line SN66E3 from Arend Mulder,
32592	monoclonal cell line MBW1
33195	JEG-3
33227	erythroleukemia K562
33337	SCLC line NCI-H841
33354	UTMC2
33408	cancer cell lines
33872	NK92.26
33908	HeLa; Jurkat
34050	DAKIKI
34136	colonic adenocarcinoma SW480
34362	breast cancer cell line, BT474
34435	HMC-1
35129	Jar
35169	SKOV-3; taxol resistant line
35203	SS254
35214	C3-A11N; clonally related variant of OCI
35245	Epstein-Barr virus strain B95-8 transformed B
35303	acyte promyelocytic leukemia HT93A
35384	tumor cell line SOJ-6
35406	NT2-D1
35542	WI38
35707	KG-1a
35809	Wish; HeLa
35942	mekakaryocyte
36059	CF-PAC1
36103	Gru-1
36301	acute myelogenous leukemia KG-1
38010	MM200
38154	GC
38177	OV177
38254	SMMU-7721
38681	H-460
38701	TC7
39062	1418-1
39068	1418-16
39072	1424
39079	T47-D
39113	HeLa, D98/AH-2, HPRT-
39127	SC-M1
39301	CEM174
39325	Raji
39457	Saos-2/B10
39498	ovarian epithelial cancer line SKOV-3
39561	184B5
39596	PancI
39619	10IHW 9022
39625	4AOH 100044V
39628	10IHW 9082
39631	10IHW 9013
39634	10IHW 9052
39637	4AOH 100083J
39640	10IHW 9090
39643	10IHW 9027
39646	10IHW 9041
39649	10IHW 9006
39652	4AOH 100108V
39679	HT-29/ino
39694	lymphoblast; prepared from SCA2 and SCA7
39712	breast cancer cell line 600PE
39724	Farage DLCL
39827	DU-145; PC-3
39832	Hodgkin cell line L428
39864	U-937
39953	KG1a
40022	MCF-7/AdrVp
40201	Ntera-2/c1.D1
40245	EBV-B
40353	SCC 9
40408	lymphoblastoid B-cell line NC37
40581	JME
42751	MCF-7/HER2
42782	EBV-transformed B cell; B-ALL
42887	BG9
42897	786-0
43042	SCC15;SCC25;FaDu
43209	SLB-I
43215	HTLV-I transformed T-cell line SLB-1
43488	CD8-1
43495	CD8-2
43503	DN1
43513	LDN5
43517	DN.POTT
43544	BjAB
43679	IgM Opp 03
43736	IgM FRI
43783	ZR-75-1
44270	IARC-EX1
44285	PMA stimulated HL60
44647	hepatoma
44698	Caco2-bbe
44725	ovarian cancer C200
44931	Saos-2
45806	COLO-205
45864	glioma U251
46011	Namalwa B cell lymphoma
46237	NCR-EW2
47090	JY
47308	DUPRO
47441	T84
47513	Jurkat T-cell leukemia
47885	SK-LMS-1
47919	E8CASS
48025	CCRF-CEM
48097	SP49
48152	Meg-01
48266	MDA-MD-468
48273	SOJ-6
48284	HT29-M6 transfected with an activated form of
48291	Nu-6-1
48738	NU-6-1
49229	L02
49255	A431
49635	SKOV-3
49946	NCI H157
49967	THP-1 monocyte-macrophage
50148	apoptotic HL-60
50212	subtype of SW 480
50326	SKN
50436	ECV304
50505	SUP-T1
50528	PC3
50639	K562, ATCC CCL-243
50642	CCRF-CEM, ATCC CCL-119
50645	KG-1a, ATCC CCL-246.1
50648	MOLT-4, ATCC CRL-1582
50671	glioma LNZ308
50734	Hela S3
51293	8701-BC; BT-474
51432	CFPac-1
53007	HT-29
53014	T84 colonic adenocarcinoma
53158	1973/10-4
53195	HT-29-M6
53208	ARPE-19
53278	SV40 virus-transformed embryonic lung
53423	LAN5
53634	SW626
53644	SCC-9
55145	MDA-MB-453
55157	HLE-B3
55202	leukemic T-cell line
55292	AHH-1
55363	melanoma cell line M88
55667	BB90-MEL
55835	K562 CML
55852	hepatoma Hep3B
55938	hepatoma cell line Hep3B
55952	697
56010	MDA MB 453
56163	ARCaP
56248	T84; HEk 293
56355	HCT-116
56768	DU145
56903	HCC
56965	F223
56984	LN319
57034	WERI-1
57040	Ramos
57236	MV4-11
57320	L428
57389	SLB-1
57698	TSUPr1
58419	HEK293; PC3
58696	Bix3
58715	1E8
59432	Hs638
59578	SS269
60902	pancreatic cancer cell line Suit S2 007
60914	LB373-MEL
61000	intestinal epithelial Caco2
61125	ovarian cancer line SKOV-3
61373	Caco-2; 407
61647	HD3
61711	GM11201 (Coriell)
61717	GM11197 (Coriell)
61817	Nalm6
61953	GM008333A (Coriell Cell Repositories)
62140	Dob1 hybridoma
62341	A431 epidermoid carcinoma
62401	MCF-7; T47D; ZR75-1; MDA-MB-453
62407	CEM x 174 (T-cell/B-cell hybrid)
62466	k562
63189	MOLT-4 T-cell lymphoblastic leukemia cell
63195	MOLT-4 T-cell lymphoblastic leukemia
63242	Mel JuSo
63654	MFC-7
63819	Lu-165
63830	Nu-6
63928	ARPE-19; from retina
64136	EA.hy926
64303	Burkitt's lymphoma
64499	H93D8 T cell
64505	Jurkat J6 T cell lymphoma
64596	MM5.1 multiple myeloma cell line
64706	NB4 treated by ATRA
64951	DJM-1
65064	Hl-60
65244	A2780
65277	T-84
65564	Hs578Bst
65604	HM7-F6
65829	SW1088
65856	brain astrocytoma (SW1088)
66490	HaCat
66548	SiHa
66578	HeLa; WI38
66585	SK-N-MC
67421	U2OS; 978SK
67523	WERI Rb-1
67589	AA/C1
67671	GT2015; GT1179
67677	IHW9001 SA; IHW9004 JESTHOM
67680	IHW9021 RSH; GT1261
67683	GT1060; GT1081
67686	IHW9251 M7
67689	IHW9272 CODI; GT2012
67692	IHW9001 SA
67695	IHW9002 MZ070782; Gt1060
67698	IHW9036 SP0010
67701	IHW9107 LKT3; GT321
67704	IHW9234 CRB; GT1183
67707	IHW9021 RSH; GT1083
67710	GT1099; GT1100
67713	GN100
67716	IHW9058 OMW; GT1061
67742	LNCaP prostatic cancer
67747	MiaPaCa-2 pancreatic cancer
67756	CAKI-1 renal cancer
68089	143B
68129	Jurkat T lymphocyte
68488	myeloid HL-60
70336	KATO III
97465	HLE_B3
98572	HOS TE85
98650	KUT-2
98686	Molt-4
98693	HCT-15
98719	MIY-3
98755	TE 6
98790	SF-HT (ATL cell line)
98800	P39
98845	AMS3
98943	SAJ022
98997	MRC-5
99034	human glioblastoma cell line, T98G
99627	QGP-1
99761	CGM1
99769	COLO 201
100010	AKIBA
100019	SH-SY5Y
100061	IMR-32
100275	NEC14
100363	embryonic carcinoma, NEC14
100382	KD
100488	TIG-1
100585	ACC-LC-170
100797	KPB-M15
100812	HepG2 liver tumor
101079	primary-cultured
101119	21
101376	ZR-75-30
101461	HUE4
101582	MCAS
101662	SK-MEL-28
101782	SMKT-R3
101798	KM-102
101806	MeWo
102037	NCC-MS-1 CDDP
102081	HIgMXL AO-EBV B
102094	KRO3 /4 (IHW 8w141)
102109	NTERA2-D1
102175	SK-RC-10
102240	Nalm-6
102376	HEK-293
102603	SV40 transformed MRC-5 fibroblasts (MRC-5 V2)
102617	Clara
102781	teratocarcinoma NTERA2
102857	fetal brain
103009	Yusiti
103059	myogenic cells
103077	daudi
103111	diploid fibroblast cell line VGS
103145	HEC-1B
103274	3D6.
103420	SH-SY5Y cells
103617	yusiti
103733	teratocarcinoma
103756	transformed human amnion cells (AMA)
103819	RF.BM, YF.PB2
103940	BC2
103945	BCBL1
103948	HBL6
104138	Therad 7 (59/19.59)
104144	therad 7 (59/19.59)
104151	Therad 10 (76/55.1)
104163	Therad 24 (174/102.21)
104275	LB129-SCLC and PBL
104396	530
104404	human malignant glioma cell line MO59J cell
104509	GTL-16
104908	518/IL2.14
104916	518/IL-2.14
105120	B lymphocyte
105133	CF Pac1
105140	GM5756T
105399	ZR75 breast cancer cell line
105617	Me18732
105859	MG63 ostosarcoma
106034	HCT 116
106040	LB33-MEL.A-1 (tumor cell line)
106174	T122.12
106217	T122.12 and peripheral blood monocyte
106236	PH63-14, PH63-15
106252	peripheral blood monocyte
106558	SP(3,4,18,24,27,42)
106562	SP(1,12,14,16,23,35)
106565	SP17
106568	SP25
106571	SP6
106574	SP20
106577	SP1
106580	SP43
106583	SP2
106588	SP8
106591	SP19
106595	SP(10,18,24,26,27,42)
106598	SP4
106602	SP(12,16,23,35)
106605	SP7
106761	SV-40 transformed
106908	MV3
107046	HSC172 (16PDL)
107675	VH-64
107690	SW613-S
107771	Colo 320
107775	HDLM-2
107780	Karpas 299
107783	KM-H2
107786	L 1236
107789	L 428
107792	Tera II
109055	NK92
109231	YAR
109308	OZB
109336	Human hybridoma
109344	Epstein Barr Virus-transformed B cells and
109347	Epstein Barr-transformed B lymphocyte and
109352	HeLa Cell
109484	SW 480
109548	AGS and KatoIII
109555	adenocarcinoma cell line AGS
109672	human medullary thyroid
109737	3C
109745	ALBA
109759	HeLa (ATCC # CCL2)
109865	HOG
110404	ROHA, Hairy leukemia cell line
110634	weri
110877	Thyrocarcinoma cell line ATCC CRL1803
111065	pancreatic adenocarcinoma cell line HPAF
111100	leukemia cell line JuanaW
111273	MOLT-4V
111292	Fetal lung
111297	Lymphoblastoid cell line, testis, fetal lung
111320	LB23-SAR
111800	721.45
112014	MCF7, T47D, ZR75-1, MDAMB-453
112043	TEM
112048	AMALA
112054	MI
112059	KGU
112064	FS
112069	FPAF
112841	adult T cell leukemia cell line JuanaW
113048	Reh
113077	IMR32
113126	mammary carcinoma, MDA MB 435
113134	Namalwa Burkitt lymphoma
113162	HISM
113175	AMA cells
113300	HSC93
113370	CBGA1
113387	MacK
113438	LEP2E9
113511	MH6
113548	EBV-transformed cell line
113555	Heteromyeloma
113574	SV80
113636	medulloblastoma TE761
113646	TE671
113664	EpG2
113729	KB100 cyt1
113766	B5-589
113795	reticulocytes
113810	SPAZ 4
113854	HS74
113868	K562 and human T-lymphocytes
113915	Osa-Cl
114100	SKOV3
114154	SK-MEL-19
114180	FIS
114207	HepG2 hepatocarcinoma
114222	AH-2
114227	AH2
114717	CCRF-CEM/E1000
114747	myelocytic leukemia cell-line U937
114794	BO2C11
115029	IHKE-1
115310	AS30
115312	AS31
115315	AS32
115318	AS33
115320	AS34
115322	AS35
115325	AS36
115328	AS38, AS42, AS44
115330	AS39
115333	AS40
115335	AS41
115337	AS43
115339	LC37
115342	LC38
115345	LC39
115347	LC40
115475	AG 1518 human foreskin fibroblasts
115484	erythroleukemia (HEL) cells
115494	LS174T.
115530	RPM18866
115719	reticulocyte
115785	hepatocellular carcinoma (FOCUS)
115822	SKW6.4
115912	HT29-MTX
115926	glioblastoma ATCC HTB14
115976	SHSY-5Y
116033	ARM/BC11 (human-human hybridoma)
116095	transformed human amnion cell line (AMA)
116102	RPMI 8226
116206	ATL-2 (human HTLV-I transformed T cell line)
116247	Lx-1
116296	IMR32 human neuroblastoma
116310	HepG2 and MOLT-4
116442	DAUDI B*4102
116459	DAUDI B*5802
116532	FLEB14-14 and HL60
116573	HT29 colon carcinoma cell line
116587	Burkitt lymphoma Daudi
116604	ATL-2
116659	EBV transformed B-cell lymphoblastoid cell
116679	KBM-5
116712	hematopoietic
116814	Kato-III
116848	HIV/U937
116898	Burkitt's lymphoma cell line BL-29
116915	BL29
116925	BL31
116932	BL36
116939	BL41
116972	IARC-BL64
116982	Colon carcinoma cell line CaCO2 (ATTC HTB37)
117060	PA-1
117073	hybridoma derived from peripheral blood
117128	Brad-3
117195	3nbHPG
117220	non fractionated non cultures normal
117267	UD53
117274	BTII 102, BTII176, BTIII 1, BTIII 13, BTIV 54
117277	BTII 141
117280	BTII 158
117283	BTII 175, BTIII 44, BTIV 32
117287	BTII 180, BTIV 13
117290	BTII 36
117293	BTII 68
117296	BTIII 53
117299	BTIII 56
117302	BTIII 60
117305	BTIII 65
117308	BTIII 85, BTIV47
117311	BTIV 58
117558	rhabdomyosarcoma line A204
117562	CA46
117571	human medullary thyroid carcinoma cells hMTC
117579	hMTC cells (human medullary thyroid carcinoma
117586	CRL 1475 (ATCC)
117651	WI38 human fibroblast (ATCC)
117670	normal human duodenum
117887	E.Coli Y1090
117896	monocytes U937 (nt 1-917)
117916	NIH3T3
117941	IM-9 (ATCC CCL159)
117948	CB-201
118101	NSO transfectant 10B3
118106	human (fresh) thymocytes
118150	CLL leukemia
118222	HPBALL
118328	NK cells
118348	BJA-B Burkitt lymphoma B-cell line
118363	qm637
118394	EBV transformed Human peripheral lymphocyte
118422	DU145, human prostate carcinoma cell line
118426	LNCaP, human prostate carcinoma cell line
118454	PC3, human prostate carcinoma cell line
118500	Reh (ATCC #CRL 8286)
118505	synovial T-lymphocyte
118540	HT1080/Dr4
118687	HER XC2 (retina)
118801	EK 4
118866	human blood
118951	ML-2
119002	CRL 1106
119053	foetal lung fibroblast HFL-1, ATCC CCL153
119064	JIMM-69
119078	HT 1080
119153	A2058 melanoma
119369	RHEK-1
119433	NTERA2/D1
119500	MIA PaCa-2
119538	human Tera-2 (EC)
119556	CTL 102DRF
119560	CTL 172DRF
119564	CTL 17A2
119569	CTL 212DRD
119573	CTL 28
119577	CTL 40
119581	CTL 5A2
119584	CTL 64DRF
119589	CTL 64.8P
119593	CTL 67DRF
119602	CTL G36
119606	CTL GM7
119628	HeLa and testis
119639	B cell
119648	ANDP
119655	BM21 (1othIHW No.9043)
119661	CW698
119688	WI38 Human Fibroblast (ATCC)
119731	A-431
119790	FOB fetal osteoblasts
119890	IGR3
120002	DA3
120062	DAUDI
120147	721.180
120155	HUT-78, ATCC #TIB161
120170	normal adult and fetal brain
120197	human liver
120205	CGL
120237	Colon Carcinoma CaCo2
120355	AMA amniotic epithelial
120454	HeLa cervical carcinoma
120465	TT cells
120481	HeLa-cells
120493	liver
120538	HT29-D4 colon carcinoma
120725	thymic
120731	NALM-6
120749	UM-SSC-22A
120912	cytoplasmic extract from Raji (Burkitts
120920	HeLa, bone arrow
121009	THP1
121092	U937-B
121111	NF1032
121224	IARC-EW11
121268	caco-2
121303	peripheral blood leucocytes
121308	CCL186
121427	GM637
121454	human epidermal cylindroma
121461	MCF7 breast cancer
121483	human fetal muscle
121518	NT2/D1
121537	SK-ES-1
121543	ZR 75-1
121690	Caki-1
121743	COLO-16
121812	E.coli XL1-Blue
121831	hsc93
121900	Human PBL
121907	human PBL
121938	diploid dermal fibroblasts
121998	K937
122007	primary resting T-cells
122069	M432
122105	primary fibroblast culture
122297	Fog-1
122302	Fog-3
122308	Fog-B
122316	Fom-1
122322	Fom-A
122325	FOM-A
122384	KG-1, ML-1, MCF-7
122407	IARC 171
122562	Gad-2
122583	HEP G2.
122659	IMR 90
122713	WM266-4
122738	K 562, Meg 01, Jurkat
122762	E6SM (embryonic strain - skin and muscle)
122961	D-259 MG
123111	non fractionated non cultured normal
123120	human fetal liver
123195	Clones A,B,C,D,E,F + Line A.1-CD8
123246	PHA activated PBL
123281	KT30
123387	primary T-cell culture
123450	multidrug resistant Adr(R) MCF cells
123456	HEP G2
123513	glioblastoma 308
123587	HUT78
123620	L1
123627	D1
123648	uninduced teratocarcinoma
123654	HAM-B
123659	C32
123774	PLC/PRF/5 (Alexander cells)
123797	EW-1 Ewings sarcoma cells
123931	human epididymis tissue
123946	human-mouse hybridoma
123959	HeLa.
123988	HePTP
124015	purified high endothelial cells
124038	J6 and CEM
124108	transformed amnion cells (AMA)
124148	GMO3299
124213	KU-812-F
124288	KLO
124297	XLI
124318	K.LIE-EBV
124326	WT51
124342	SLUGEO
124375	lymphoblastoid cell line DCH013
124388	RML
124395	MAD61
124409	Kime
124416	Lymphoblastoid cells lines
124429	CR-B
124441	M54672
124458	GO85
124462	ENA
124466	MASCH
124470	CC
124475	25-1501
124479	MALS
124486	WWAI
124494	lymphoblastoid cell line DCH036
124502	GSW002
124508	Ci
124516	GB32
124522	SBD4
124536	GB92
124542	WM1361C
124549	LCL721
124559	B-lymphoblastoid, NDS-DG
124575	LE023 HLA phenotype A26,32; Cw1,-; B51,73;
124588	PAR HLA phenotype A11/24, B27 /48, DR11 /15,
124594	TAN
124615	bLcL(B-cell)
124619	OMW
124623	SH.JO
124627	3232
124641	2085(HLA-A1,29 Cw6sh,BL B52,61 DR14,15 DQ5,6)
124648	C073, HLA phenotype A2/29, Cw2 /Cw6.2, B44/51,
124655	2085
124660	2088
124667	CO47
124687	GB86
124712	GB002
124719	LUY (IHW 9070)
124729	GB2
124751	LG2
124758	TUBO
124777	MOLT-4, clone=M4-117
124796	LEO23 HLA phenotype A26,32; Cw1; B51,73;
124887	HeLa cell line
124901	RPMI4265
124908	DLD-1
124917	PLC/PRF/5
124950	MRC5
125010	ZR-75-1 (human breast carcinoma)
125116	SCLC-10
125123	Small Cell Lung Cancer-10
125167	peripheral blood mononuclear cells
125229	hepatoma G2, leukaemia Molt4
125341	CMD004AN
125370	HEP-G2
125379	A549, ATCC #CCL185
125386	ZR-75-1, ATCC CCL119
125426	NH17
125554	HT 1080 (fibrosarcoma, ATCC CCL 121)
125586	Wish cell
125597	HN.F1BB5 (human-human hybridoma)
125639	human hepatoma cell line,Hep G2,ATCC HB 8065
125672	NTERA2-1
125694	NTERA1-D1
125724	FS-4
125756	HEP G 2
125764	OVCA432
125850	Jurkat leukaemic T cell
125872	4251 astrocytoma
125898	HEL cell (Flow 2000)
125933	Total human foetal liver
125957	E.coli dM105
126084	CLL001 x HMMA 2.1 heterohybridoma
126091	CLL030 x HMMA 2.1 heterohybridoma
126096	CLL033 x HMMA 2.1 heterohybridoma
126102	CLL039 x HMMA 2.1 heterohybridoma
126105	peripheral blood B cells
126108	CLL040 x HMMA 2.1 heterohybridoma
126113	CLL055 x HMMA 2.1 heterohybridoma
126118	CLL057 x HMMA 2.1 heterohybridoma
126296	hybridoma ED8.4
126302	U266BL
126324	F1.1
126341	Farage
126369	WS8
126400	HepG2 Hepatoma cells
126416	G1.1
126423	human /mouse (NS-0) hetero-hybridoma cell line
126486	D10.E6
126490	B12.F8
126524	RSP-4
126528	RH 14
126533	T33-1
126535	T33-2
126538	T33-4
126540	T33-16
126543	T33-17
126546	T24-9
126549	T33-20
126564	hybridoma cell line: GAN4B.5
126571	EBV transformed B cell line R 149
126574	RSP-1
126579	GM 4672
126704	J2.2
126709	BL JBL2
126716	Ly66
126721	Ly91
126732	rescue fusion 1b11.
126735	rescue fusion 1h1.
126752	rescue fusion 2a12.
126755	rescue fusion 2c12.
126824	9F12 (ATCC no. MB 8177)
127126	human-mouse-heterohybridoma P61B27
127141	CLL B lymphocytes
127146	Epstein-Barr transformed lymphoblastoid cell
127225	HF_21/28
127242	Ly47
127267	rescue fusion k4h8.
127270	rescue fusion k5b8
127273	rescue fusion k5c7.
127276	rescue fusion k5g5
127279	rescue fusion k6f5
127282	rescue fusion k6h6.
127285	hybridoma LSF2
127291	4G12
127313	BL Ly47
127319	BL Ly91
127327	SSK41
127333	lymphoma 201
127357	hybridoma
127368	mAb 61
127372	Ab 63
127381	Nalm-1
127386	4G12 hybridoma
127439	hybridoma Ray 4
127525	RF-KL5
127531	RF-MR2
127536	RF-MR25
127539	RF-MR28
127542	RF-MR30
127545	RF-MR33
127548	RF-MR37
127551	RF-MR1
127557	RF-MR13
127560	RF-MR16
127563	RF-SJ5
127574	RF-TS7
127584	RF-MR14
127589	CM3.B6
127593	hybridoma SB1/D8
127596	hybridoma SB5/D6
127599	T1.1
127601	T34-1
127603	T20-24
127605	T20-11
127607	T21-9
127609	T23-9
127611	T24-3
127618	immunoglobulin phage display library
127698	CLL-12
127703	CLL-27 EBV
127709	LAZZ-21
127715	EBV-21
127889	GM2132
127962	EBV383
128135	CAKI-1
128157	NCIH69
128163	NCIH82
128176	THP.1 - acute monocytic leukemia
128188	CB233
128240	Namalwa
128275	YT
128282	TCL-Na1
128320	IM-9
128417	uninduced male teratocarcinoma, NT2 /D1
128468	FG
128477	HPB-MLT
128508	Primary explant, passage 4 to 10
128528	Jurkat-111
128536	Jurkat III
128784	M10
128814	5583S
128839	CAPAN I
128881	Jac-10
128908	B-lymphoblast RPMI 8866
128938	JI
128942	JIJOYE
128955	AML,KG-1
129112	5583-S
129120	L540, YT, K562
129165	Molt 4
129202	Jurcat
129320	HOC-8 (ovarian carcinoma)
129335	UCLA-P3
129368	NTera-2
129393	U937 Lymphoma
129445	SSC25
129584	F55IIIE5
129652	human keratinocyte
129658	SCC25
129686	human placenta, human colon carcinome
129750	BeWo
129788	IB4 (human B cell, human tonsil)
129822	COLO201
130030	C10-MJ2
130096	LJ 1
130102	RPMI 4265
130175	AG1518
139321	Mad-2
139337	U937 PMA-stimulated
139356	human thymocytes
139377	NT9D1
139419	SKBR-3
139456	Burkitt lymphoma Daudi.
139482	Hep62
139489	MCF-7.2.2
139505	Hep-2
139515	U105MG
139574	A375met
139628	WM 1158
139634	SCLC-6
139649	ML3 (acute promyelocytic cells)
139674	MV3 melanoma
139696	GTL16
139704	Raji (Mer+)
139712	600 PEII
139747	melanoma HTZ19
139755	Hs294T melanoma
139775	Hela, IMR90
139788	MICA 1
139795	MICA 2
139801	MICA 3
139807	MICA 4
139813	MICA 5
139820	MICA 6
139826	MICA 7
139854	normal adult human epidermal melanocyte
139861	HeLa S3 ATCC CCL 2.2
139876	IM9
139902	primary human skeletal muscle culture
139966	THP-1 (ATCC TiB 202)
139973	JURKAT T CELL
140014	bone marrow
140092	HL-60 promyelocytic leukemia cells
140181	RPMI 8226 and U266
140189	PHA/PMA stimulated T cell
140223	PLC/PRF/5 (Alexander)
140403	Namalwa line NM864, NM878
140412	ATCC HTB 17 U-373 MG
140439	fetal lung cDNA
140473	human breast cancer cells
140550	IN 157
140605	EPG85-257RNOV
140699	HMP2
141021	Kelly.
141027	primary myoblast/myotube culture
141047	GLC 28, Kelly
141130	 KM-3
141149	HELA
141185	cEM
141215	neutrophil granulocyte
141269	IMR 32
141298	NK 3.3
141310	NK B22
141431	MV1
141446	LS 180
141491	NTERA2
141496	LCL
141525	1.Hepatoma, 2.GM637 fibroblast, 3.HeLa
141587	Hs683
141649	U251
141687	Oak-3
141701	Raji cell line
141741	NTera2D1
141748	BJAB
141787	Og-31
141861	BJA-B
141907	HBL100/RAS1
142143	AKATA
142150	IARC/BL2
142152	IARC/BL30
142154	IARC/BL37
142156	IARC/BL41
142158	LOUCKES
142160	NAMALWA
142163	P3HR1
142165	RAJI
142167	RAMOS
142258	HBL100
142262	Pag-1
142295	HEP G2 hepatoma
142326	MCF-7ADR
142334	purified primary HEV endothelial cells
142380	ARMS282A
142393	Hut 78
142410	T15-42
142418	T33-5
142420	T33-14
142435	A9A2Br
142629	tera 2  /clone13
142635	U-2OS osteosarcoma cells
142660	Tera2 cl13
142801	EBV transformed cell line H2LCL typed
142808	EBV transformed lymphoblastoid B cell line
142890	1-gt11-library
142985	RT112 (bladder carcinoma)
143000	TF-1, KG1a
143125	nasopharyngeal carcinoma
143145	human peripheral lymphocytes
143201	A2058 (ATCC)
143212	hTera2D
143230	patient #22 cells
143233	patient #8 cells
143235	patient #30 cells
143237	patient #31 cells
143240	patient #13 cells
143244	patient #32 cells
143247	patient #28 cells
143321	Melanoma cell (Bowes)
143555	NTERA2-cloneD1
143638	Human 293S from Dr. B.Stillman (NY,USA)
143643	Human 293S from Dr. B.Stilliman (NY,USA)
143652	PDL 27
143754	foetal liver spleen 1NFLS
143808	MKN-45
143839	KG-1 (ATCC CCL 229)
143848	LE-9211RC
143913	T47D, mammary carcinoma
143932	T-cell leukemia JURKAT
143952	SK-BR-3
143996	breast cancer cell line SKBR-III
144080	EK4
144104	breast carcinoma ZR-75-1
144235	pheochromocytoma
144266	HeLa S3 (ATCC #CCL2.2)
144298	RAJI human lymphoma
144314	HL60 (1)
144420	NEC
144462	HeLa, CHP100
144472	EJ bladder carcinoma
144479	Ca. SW850
144487	Reg-A
144516	NTERA-2/D1.
144531	U937 and peripheral blood mononuclear
144713	11-50
144717	11050
144720	HMST-1
144742	CEM, U937 (gamma interferon induced)
144751	NBC
144809	HUT-78
144821	GLC28
144904	5637
144994	ewing
145001	WI-38 human lung fibroblast
145017	HL-60, Y-79
145039	Manca B
145056	B-LCL
145091	human lymphoid cell line
145127	CA2
145156	H2LCL
145256	NTERA-2
145280	Daudi Burkitt lymphoma cell line
145295	human thymus
145301	human thymus 3 year caucasian male
145355	Raji lymphoma
145441	HCT116
145508	AMA (transformed human anion cells)
145626	SW-1573/1R50b
145666	human periferal lymphocytes
145713	HT29-M6
145765	raji
145885	A
145917	tumor cell line U251-MG
145954	HEP-3B
146006	heterohybridoma
146242	lambda gt11 cDNA
146569	T47D breast tumour
147015	melanoma cell line SK29-MEL-1
147041	human placenta
147309	LT5-1 melanoma cell line / normal melanocytes
147345	foetal spinal cord RNA
147414	Raji: burkitt lymphoma cell line
147422	HepG2, liver tumor stimulated with IL-1
147437	Ishikawa
147466	adenocarcinoma cell line
147550	SW613-S clone 3
147588	ST486
147596	Human teratocarcinoma
147690	cancer cell line HT-29/M6
147782	HL60 cells
147791	KU812
147819	cultured foetal human lung fibroblast
148175	EBU transformed: T14
148180	EBU transformed;T14
148330	ALL-1
148427	DX3
148513	HA1.7
148521	DE49
148525	DH15
148686	T cell clone (TCC) 4:1.1
148689	T cell clone (TCC) 4:14.4
148692	T cell clone (TCC) 4:2.15
148695	T cell clone (TCC) 4:2.20
148701	T cell clone (TCC) 4:3.1
148704	T cell clone (TCC) 4:7.4
148775	Jurkat and HPB-ALL
148891	ALL1
148912	MANN
149342	PBL clone 25-244
149345	PBL clone 26-331
149357	PBL clone A96
149360	PBL clone 81-20
149368	PBL clone 82-1
149371	PBL clone 82-82
149376	DE26
149380	DD11
149383	DH12
149387	de5
149397	PBL clone 119
149401	TIL clone A21
149404	PBL clone A81
149413	TIL clone A36
149429	acute lymphocytic leukemia T cell line
149483	RB2
149595	DE5
149614	TIL clone A25
149674	IW6
149719	CL-1
149747	PEER
149872	MOLT13 leukemia
150002	T cell clone Mb11
150191	Tera-2 (EC)
150229	activated HUT78 cells
150236	RPM 4265
150241	A2243 synovial sarcoma
150275	preB cell
150298	SW613S c13
150312	A172 glioblastoma
150360	FOB-cells
150381	pituitary adenoma
150429	KB cell line
150469	GIN-1
150680	23.4 11+, HT-29.
150689	LOVO (ATCC CCl 229)
150931	HeLa and KB/6b
151024	22-12b (murine NIH3T3 cell line) transformed
151032	HT1080 and M426
151041	islet-specific T cell line
151072	LASTD teratocarcinoma
151093	Hela (nucleotides residues 1-200 only)
151100	human leukemia cell line
151163	T-cell clone LB117
151184	T-cell clone LB207
151188	T-cell clone LB210
151196	CII
151218	T-cell clone WM14
151225	tertiary tumor from transfected NIH3T3 cells
151231	transfected NIH 3T3 cell
151247	Daudi cell line
151264	MOLT17
151281	CII.
151359	NIH/MDA-2
151372	NIH 3T3, MDA-MB231
151732	NF861
151752	Human placenta
151821	human brain poly(A)+ RNA
151848	HT-1080 (ATCC CCL121)
151902	K422
151928	tumor material JN
151932	tumor material KD
151936	tumor material MM
152013	T-cell lymphoma PEER
152038	NTERA2D1
152069	S7 human melanoma cells
152138	BL979
152180	melanoma H3606
152189	293, Akata, Nalm-6, HeLa
152197	BL-29
152257	B5/589
152285	A-704 cells (ATCC HTB 45)
152299	Hs294T cells (ATCC HTB 140)
152309	RH30
152329	U188-MG
152338	Kcl22
152346	MRC-5 V2
152392	K-562 human erythroleukemia
152434	GEE018
152476	mg63
152509	MG-63, osteosarcoma cell line
152525	PL-1
152539	M7
152576	HPB-ALL T cells
152634	MGAR (9014)
152641	W7079
152657	clone 22 (T cell)
152665	PP
152691	MonoMac 6
152711	GM6061B
152727	AMc
152745	cc102
152751	SHSY5Y
152757	CL170
152762	20015
152767	10243
152787	JY EBV B lymphoblastoid line
152835	colon carcinoma LIM 1215
152857	LK707
152865	SV48 thymic stroma
152948	SU-DHL-1
153054	Hep 3B
153072	M426 cells
153110	melanoma cell line, 501mel
153133	LUY
153142	H929
153179	WDV
153183	DO208915
153188	LK
153229	human x mouse heterohybridoma CA4
153236	RSH
153248	olga (9071)
153269	SAOS-2/B10
153290	Culture 10
153295	Culture 5
153349	CF/T43
153354	PHA Blast ST-EMO
153366	RSH 9021
153372	HSB2
153389	NTera2/D1
153777	Culture 5(Vb17+/Va2.3+)
153782	Culture 5(Vb17+/Va2.3-)
153822	CMK11-5
153829	CCRF-CEM acute lymphoblastic leukemia
153838	hepatoma G2 cell line
153906	ALL-1, KCL-22
153917	cell line IM-9, ATCC CCl159
153921	Dakiki
153925	Burkitt's lymphoma-derived cell line Davdi
153929	Human lymphoma-derived cell line MC116 (ATCC
153932	myeloma-derived cell line IM9 (ATCC CCL 159)
153936	lymphoma-derived cell line MC116 (ATCC CRL
153939	myeloma-derived cell line RPMI 8226 (ATCC CCL
153945	Jurkat T cell leukemia line
154006	YT (natural killer-like)
154012	PBL
154068	22-12b (human met-transformed NIH3T3 cell
154102	HeLa D98/AH-2
154243	LBF (LBUF, 10W9048)
154249	gingival fibroblast
154271	HRPE cell line #165
154284	ATCC CCL136
154297	CCRF-HSB2 (ATCC CCL 120.1)
154345	OsA-CL
154454	YT, HUT-78
154552	LB33-MELc1
154564	AP630
154570	BL41/B95-8
154711	DM150
154734	PA-1 human teratocarcinoma
154757	BJAB human B lymphocyte cell line cDNA
154809	A3.01
154897	B lymphoblastoid
154970	Gw144
155057	normal human peripheral blood-derived
155084	HL-60 neutrophils
155137	JC11
155161	HeLa, subclone D98/AH-2
155340	CEM T-cells
155505	BM14
155544	DD18
155554	DD2
155561	DD22
155565	DD30
155572	HD22
155579	HD40
155586	HD47
155595	HD51
155605	HD53
155612	HD54
155619	HD56
155626	HD59
155635	JC14
155639	JC16
155646	JC18
155653	JC2
155661	JC3
155666	JC5
155672	JC9
155678	JD22
155685	JD5
155689	MC13
155696	MC14
155705	MC19
155712	MC36
155719	MD28
155726	MD30
155732	MD31
155738	MD32
155745	SC2
155752	SC24
155758	SC28
155768	SC3
155773	SC30
155779	SC31
155785	SC32
155791	SC33
155798	SC34
155803	SD15
155810	SD19
155814	SD21
155875	IMTLH
155910	PC-3 prostate carcinoma
155974	megakaryoblastic cell line M07e
155998	human keratinocyte cell line SCC 12-F:
156058	GM5424
156063	GM0435
156132	peripheral blood
156158	Y-79 retinoblastoma
156393	EBV transformed B lymphoblastoid
156474	MOLT4
156569	GN032
156572	GN037,GN041
156575	GN033
156648	ODM-2SV40
156662	A8496
156712	interferon-treated U cells
156752	HC10
156994	MZ2-MEL.43
157030	ATCC TERA-1
157082	ASKMN
157128	K562 erythroleukemia
157150	K562.4CF
157168	H441
157174	ZR-75-1 (ATCC#CRL 1500)
157184	888 mel
157205	mAb 10.2.3
157219	lymphoblastoid JY cell line
157302	Jurkat T-cell leukemia line
157319	U118-MG
157387	BL29 Burkitt's lymphoma
157433	LB33-MEL.A-1
157580	CF
157584	BPot
157727	osteoblast primary culture
157804	BT-20 breast cancer cell line
157810	K562 leukemia cell line; HEL leukemia cell
157839	Hep3B
157851	Hela cervical carcinoma
157902	U-937 histiocytic lymphoma
157956	A10
158037	NK3.3
158073	Hep 3B hepatocellular carcinoma
158119	Hela D98
158131	EBV-transformed lymphoblastoid cell line
158176	DMS-79 small cell lung cancer line
158225	HeLa S3, exponentially growing, ATCC #CCL 2.2
158254	SCC83-01-82
158513	breast cancer cell line ZR75-1
158561	TT
158633	2E9 anti-cryptococcal monoclonal antibody
158638	3B6 anti-cryptococcal monoclonal antibody
158777	EBV-transformed cell line DH
158796	THP-1, an acute monocitic human cell-line
158829	ST90-375
158831	ST93-724
158906	HL-60 promyelocytic cell line
158981	HeLa S3 cells; grown to semi-confluency
159037	RD105 and RD105U
159042	RD105
159075	Ad-312/SV40 cell line established from primary
159078	Li-538/SV40 lipoma cell line
159082	LM-30.1/SV40 leiomyoma derived cell line
159086	Li-14/SV40 lipoma derived cell line
159139	SKBR3 and ZR-75-1
159146	TE85
159153	143,2
159163	myeloma, U266
159223	YUSITI
159335	T84 cell line
159564	acute promyelocytic leukemia HL60
159586	HT-29 carcinoma
159644	MGR-1
159660	EBV transfected cell line RB22
159694	melanoma 530
159807	WI-26 VA4
159850	gn045
159871	hepetoblastoma HepG2
159908	RJ2.2.5
159918	CLL 1.19
159923	CLL 1.32
159935	CLL 1.69
159939	CTM 8958127
159991	hela cells
160092	Mz-ChA-1 cholangiocarcinoma cell line derived
160159	SMS-KAN
160251	GN097
160270	LA1-5S
160276	HUT-78 T cell library
160478	SW480, SW1463, SW1417, SW837, SW948, SW620,
160588	HeLa S3, exponentially growing, ATCC# CCL 2.2
160611	non-small cell lung carcinoma cell line
160730	acute promyelocytic leukemia NB4
160904	Lopez (NK cell leukemia)
160988	EBC transformed cell line LIE
161061	EBV-infected cell line: ML108
161071	TC-206
161078	Raji Burkitt's lymphoma
161206	HeLa cell subclone D98/AH2
161397	EC8712
161572	T-cell line Jurkat
161648	EBV transformed B cell line G1
161719	FM454
161752	MAME
161756	CTL 11DCJ
161758	CTL 12DCJ
161760	CTL 15DLH
161762	CTL 13DCJ, CTL 31DCJ
161764	CTL 18DLH
161766	CTL 23GLM
161770	CTL 28DLH
161772	CTL 49GCP, CTL54GCP
161774	CTL 36DLH
161776	CTL 37DCJ
161778	CTL 39GLM
161780	CTL 3.8DLH
161782	CTL 42GCP
161784	CTL 42.8GLM, 71GCP
161786	CTL 43DCJ
161788	CTL 5DLL
161790	CTL 48GLM
161792	CTL 56GLM
161795	CTL 5DCJ
161798	CTL 62GCP, 63GLM
161800	CTL 70DCI
161802	CTL 81DCJ
161804	CTL 74GCP
161806	CTL 77GCP
161810	CTL 7DCI
161813	CTL 81GCP
161818	CTL 26GCP
161820	CTL 29GCP, 54GCP
161833	CTL 42.8GLM, 71GCP, 74.8GCP
161842	CTL 62GCP, CTL 63GLM
161944	lymphoblastoid; normal diploid fibroblast
161953	NCI-H441 lung adenocarcinoma
161998	SV-80: human fibroblastic cell-line
162060	KB, HeLa, OVCAR-3
162086	LB96-SAR
162115	Jurkat T-cell line
162129	BEN cell line, Moseley, J.M. et al. (1987),
162231	EBV transfected cell line AA859
162236	MCF-7 human breast cancer cell line
162250	HT1080 fibrosarcoma
162275	EBV transformed cell line TC106
162283	EBV transformed cell line, TC106
162325	OsA-Cl
162379	MDA-MB-468 mammary epithelial carcinoma
162386	MDA-MB-468 mammary epithelial carcinoma cells
162542	hybridoma Ann23
162585	human glioma cell line G61
162591	megakaryocyte lines CMK11-5 and DAMI
162674	Jurkat T cell line
162680	Jurkat T
162720	Hela S3, exponentially growing (ATCC# CCL2.2)
162724	Jurkat T-cell line, ATCC E6-1
162743	neo6/C8161.1
162806	heterohybridoma:46E7
162810	heterohybridoma:43f10
162813	heterohybridoma:28e4
162816	heterohybridoma:26c1
162819	heterohybridoma:25f5
162822	heterohybridoma:24a5
162825	heterohybridoma:21h9
162828	heterohybridoma:19a5
162831	heterohybridoma:13e10
162834	heterohybridoma:13d2
162837	heterohybridoma:46e7
162909	breast cancer cell line
162926	ALL cell line HB11;19
163027	Jurkatt T cell line
163033	B6B7
163057	Jurkat leukemic T cell line
163111	EBV transfected cell line ML108
163324	EBV transformed B-cell line GN090
163342	Daudi and CCRF-CEM
163416	peripheral blood T cell line stimulated by
163479	MT-2, HTLV-1-infected lymphoid cell line
163493	breast carcinoma cell line ZR-75-1 (ATCC CRL
163553	SH-EP1 neuroblastoma cell line
163624	HeLa, RL95
163930	mammary tumor (ductal carcinoma) cell line:
163947	MCF-7 human mammary
163960	CaCo-2
164263	mammary epithelial cancer cell line MCF-7
164293	Chromosome 6 Suppressed Melanoma Cell Line
164305	SCLC line MM-1
164332	mammary epithelial cancer MCF-7
164398	W652D, Epstein-Barr transformed
164420	leukemia cell line HL60
164539	normal human primary keratinocyte culture
164571	choriocarcinoma cell line, JAR
164603	SKH1
164701	lung adenocarcinoma A549 stably transfected
164757	oral cancer cell lines SCC15, SCC25.Hu
165014	HeLa cell R19
165026	CEM human T cell
165063	B-lymphoblastoid cell line AZH
165096	CAL44 cervix uteri carcinoma cell line
165102	RPMI 8392 B lymphoblastoid
165132	EBV-cell lines ML108 and ML108U
165211	MDA-MB-231 breast carcinoma cell line
165247	megakaryocytic cell line MO7e
165302	ML108; ML108U
165341	CEM cells
165431	HAL-01; B-cell progenitor cell line
165502	hepatoma HepG2
165607	astrocytoma cell line
165706	CHRF288-11
165728	Jurkat E6 cells
165738	teratocarcinoma NTera2D1 cell line
165742	THP-1 cells
166077	glioblastoma cell line
166179	adenocarcinoma Caco-2
166196	232132/87 from gastric cancer
166283	MGR3
166342	21PT
166367	370 glyoma
166448	osteosarcoma cell line
166464	GN015
166488	HEpG2; HUVEC
166520	Epstein-Barr transformed B-cell
166584	MCF7; ATCC HTB22
166790	EBV transformed B cell line 19662
166832	LB33-MEL.A
167412	Louckes
167569	U118 glioblastoma
167613	H146
167659	OVCAR-3
167685	WI-38; K562
167826	A70
167830	437.3
167834	EBV transformed cells
167895	PCI-O6A
168099	MCF-7 breast cancer cell line
168210	G292
168294	PHA-PBL
168391	pancreatic cancer cell line Patu8988t
168413	HT-29 and Caco-2
168496	EBV cell line WAI047
168729	Patu8988s
168745	amelanotic melanoma; LOX
169041	LIM 1863
169219	cisplatin resistant cell A2780 E(80) derived
169225	cisplatin resistant cell line A2780 E(80)
169329	KLE
169348	Epstein-Barr virus-transformed B-cell LAZ-388
169610	Manca B cell lymphoma
169666	LIM1215
169683	t(15;17) acute promyelocytic leukemia NB4
169927	Namalwa B
170318	EB virus-transformed human B cell line
170436	CD34+
170558	C1R
170568	Raji; B cell line
170638	Epstein-Barr transformed cell line
170722	T-cell
170872	breast carcinoma line MDAMB435
170894	EBV transformed B cell line
171012	T antigen-transformed diploid fibroblast
171050	MCF7 human breast carcinoma cell line
171161	DM0
171166	DM1
171171	DMId3
171174	DMId5
171318	MBW1
171367	NCI-H322
171497	C8161
171615	U87 MG
171685	leukemia H9
173062	BON
173352	L55
173417	T98G
173457	U937 histiocytic cell line
173825	EBV-transformed Korean B-cell line CH
173832	EBV-transformed Korean B-cell line KT
173838	EBV-transformed Korean B-cell line JS
173863	hybridoma 1C9
173937	immortalized first trimester human trophoblast
173943	monoclonal cell line 3.B6
173948	monoclonal cell line 1.H9
173950	monoclonal cell line 1.C8
173955	monoclonal cell line 5.G3
173959	monoclonal cell line 10.2.5
174052	PaTu8988t
174177	primary human foreskin keratinocytes
174184	primary foreskin keratinocytes cell line
174253	MKN45 (gastric)
174271	haemopoetic
174281	UK4
174325	HEC-1-B (ATCC)
174341	NIH3T3 cells transformed by human DNA
174418	P54
174466	medullary thyroid carcinoma
174548	LCLC97
174587	AB12
174620	AIDS-KS 3 cells
174627	PC-3 (ATCC CRL 1435)
174760	EBV
174898	HS 766T
174903	BL2
175039	Ab 60
175045	Ab 61
175052	Ab 65
175057	Ab 67
175065	genomic DNA
175082	peripheral blood from CLL patient P2
175086	peripheral blood from CLL patient P28
175089	peripheral blood from CLL patient P29
175092	peripheral blood from CLL patient P30
175095	peripheral blood from CLL patient P32
175098	peripheral blood from CLL patient P34
175101	peripheral blood from CLL patient P4
175105	peripheral blood from CLL patient P46
175108	peripheral blood from CLL patient P48
175111	peripheral blood from CLL patient P53
175114	peripheral blood from CLL patient P7
175154	HT29-18C(1)
175234	fetal bone marrow
175246	E29.1
175448	ME180
175656	uninduced male teratocarcinoma cell line
175725	GM6061B lymphoblast cell line
175821	Raji, Mann
175905	PATU 8988s
175994	PATU 8988s (pancreatic adenocarcinoma)
176102	Patu 8988s
176351	NDS-JD
176435	KT30 (CD4+ T cell line)
176459	Lymphoblastoid
176489	MG63 (osteosarcoma)
176567	ZR-75-1; breast cancer cell line
176762	LB831-BLC
177051	RT6 hybridoma
177842	ROF-NL
177859	MG63, HL60
177891	HelaS3
177935	K562 erythroleukemic
177959	serum starved CEM
177993	T-cell lymphoma (PEER)
178041	123AV16-1
178297	GM 639
178511	RD(CCL 136 human embryonal rhabdomyosarcoma )
178610	neuroblastoma IMR32
178619	HT29-18
178651	0041 (M. Del Monte)
178732	chronic myelogenous leukemia cell line EM2
178750	simian virus 80 transformed fibroblast cell
178755	chronic myelogenous leukemia cell line K562
178779	SW 1116
178801	BEN
178842	HeLa (D98/AH-2)
178915	MG-63
178933	THP-1 (Phorbol ester activated)
179110	HH-16
179185	HuH-7
179205	AGS
179275	HT144
179280	HT-144
179461	UMSCC2
179600	Kasumi-1
179620	SK-Mel-28
179628	SK-Mel-28 (ATCC HTB 72)
179726	hepatoma G2
179796	human glioma explant HS 683 (ATCC # HTB 138)
179907	HMMA2.11TG/0
179985	YN-1-0-A
180134	Li7
180330	breast cancer cell line MDA-MB 231
180348	ags
180368	HepG2 cells
180612	ATL-16T
180620	intestinal mucosa teratocarcinoma cell line
180692	HEPG2
180783	A2058; established from brain metastasis
180798	B5.65
180990	Namalwa and UOC-B1
181068	ATCC A253
181173	GM06141A
181227	promonocytic cell line U937
181325	23.411+ genomic transfectant
181330	delta 6 from MIA PaCa (ATCC CRL 1420); B3-3
181357	CCD-16Lu
181430	NCI-N417
181456	cultured human keratinocytes
181475	Osteosarcoma cell line, MS
181544	BJA
181552	KATO-III
181590	Hela cells
181608	E. coli DH5 (pjptHUMB)
181622	HT-H
181630	K562 human erythroleukemia
181701	placenta cDNA
181826	of S.L.C.Woo
181915	C-Li21
182123	184N
182160	BIN-67
182204	43D-Cl2
182351	AGS 1-6-30-1
182374	W38 and U2-OS
182416	hep G2
182432	differentiated HL60
182559	con A induced PBL
182568	HUT-102
182587	K562/ADM
182646	JY + DAUDI
182654	promyelocytic tumor cell line HL60
182729	U118
182775	TIG3
182905	pBluescript
183028	melanoma SK-Mel-28
183059	LS174T
183212	HPBL MLTC(-)
183298	glioblastoma
183436	hepatocellular carcinoma; FOCUS
183713	86-226
183925	erythroleukemic K562
184326	Li21
184426	Human glioblastoma U118
184431	Jujkat
185914	KB cell
186108	ATCC TIB 161
186383	B6.6
186388	HL60R
186396	EBV-transformed peripheral blood lymphocytes
186477	HuH-6
186491	Nalm 6
186580	ACHN
186600	HeLa and keratinocyte
186607	mononuclear cord blood cells stimulated with
186719	CHP100
186809	HEC
186890	COLO 320
186904	K562 human erythro leukemia cell line
186923	LX-1
187001	neuroblastoma IMR-32
187092	HEL; MLT; Daudi
187107	Chang liver
187169	cervical cancer cell line cc-7T
187195	JURKAT
187269	HTB119
187397	RH
187427	unfractionated non-cultured keratinocyte
187459	A204
187561	U1242MG
187787	D65MG
187811	CML K562
188199	PHA/PMA stimulated Jurkat cells
188413	Li-7
188439	K562 cell line
188452	SW948
188503	GaCa
188579	Ht-1080
188690	RD-ES-1, A2095
188710	Hut78
188737	FS-2
189092	AC5
189181	xenograft D245MG
189216	HGT-1
189248	G2
189363	TC79-842
189444	M-07
189456	BeWo choriocarcinoma
189826	NCI-H345
189948	ZR-75-1 0)
190040	3B6
190220	human erythroleukemic (Hel) cells
190344	HEL 92.1.7
190353	KU-812F
190378	HeLa and HPB-ALL
190386	LK63
190421	A631
190486	RL95-2
190753	EBV Transformed B Cell line, B*5401 cDNA
190758	EBV TransformeVEN is an EBV Transformed B Cell
190763	EBV TransformeAPA is an EBV Transformed B Cell
190772	ENA is an EBV Transformed B Cell line, B*5602
190792	homozygous typing cell line SA
190794	homozygous typing cell lines MADURA, AMAI
190801	KT14
190820	MIY-1
190831	BH, VH, GTI3, GTI4
190853	HGOM
190865	JAP-NF
190873	NV
190879	35020
190884	MIY-2
190936	KAS116(9003), EMJ(9097), KAS011(9009) and
190940	EK(9054)
190943	AK93007
190946	MOU(9050), BOLETH(9031) and YT
190949	DKB(9075)
190952	SPACH(9072) and LUY(9070)
190955	VAVY(9023), BM16(9038) and AMALA(9064)
191022	HERLUFF
191041	QGP-1NL
191053	B-LCL CODI
191059	human monocyte
191189	TIG-3
191198	Namalva
191283	PER-225
191383	HPBL3x
191393	hystiocytic lymphoma monocyte-like cell line
191456	DOND
191462	KK
191467	GM6804 (Human Mutant Cell Repository, Camden
191632	EBV transformed B-cell
191659	WiDr; CRL 1262
191712	HT-1376
191733	gamma-interferon-induced HeLa
191922	SUP T1 lymphoblast
191936	U-373MG
192004	MG-63 osteosarcoma, (ATCC CRL 1427)
192101	SV40-transformed cell line MRC-5
192140	CTL/NK cell
192265	FS4
192403	T61 transplantable braet tumor
192427	HCV-3
192431	HCV-63
192434	HCV-65
192437	HCV-2
192470	hybridoma cell line, mAb-57
192512	265-695
192514	MD3-4
192516	OST577
192518	ZM1-1
192523	Human-mouse trioma cell line
192746	CB33
192767	BH1
192812	L612 EBV transformed B cell
192839	hybridoma 87-2
192931	417.32F4.8.5
192935	416.F2.2.34
192937	417.F25
192940	417.F21.5
192942	417.F14
192945	417.F22
192948	417.F1.1.35
192950	417.F23
192952	417.7.3.1
192954	417.F29
192956	417.32.F24.7
192959	417.F33.3
192961	417.F32.36
192963	417.F32.26
192965	417.F28
192967	417.F9.5
193004	LSH6
193046	9702
193049	B8801
193105	Kim4.6
193113	F3b6 mouse x human
193119	MO30
193125	9604
193128	B122-2
193130	B6204
193134	B8807
193136	B8815
193138	C119
193140	C471
193145	L2B5
193148	L2B8
193151	L2BS1
193154	L2D10
193157	L2E7
193159	L3G11
193162	s4D5
193164	s5A10
193183	s5D11
193185	s5D4
193188	s6A8
193190	s6C8
193192	s6E11
193195	s6H12
193197	s6H7
193199	s6H9
193313	SSH23
193368	lymphoblastoma
193433	MO58
193436	MO53
193439	MO81
193442	MO61
193550	16M3C8
193556	Hib JB32
193559	RC3
193570	HAF10 human-mouse heterohybridoma
193576	LBR 295
193582	LBR 962
193585	LBR 1045
193587	LBR 1189
193590	PHB 1213
193595	KES 643
193601	LBR 150
193604	LBR 271
193607	LBR 1104
193613	MRE 148
193619	hybridoma M7B5
193623	hybridoma T15G1
193654	NG9/9.1 hybridoma
193662	human-mouse trioma cell line
193795	RPMI 6410
193833	2E7
193837	hybridoma RC3
193846	hybridoma ED6.1
193850	lymphoblastoid cell line
193854	9500
193907	L2B10
193910	L2E5
193913	L2E8
193916	L2F10
193919	L2H7
193922	L3A10
193929	L3B2
193932	L3B6
193935	L3G5
193938	L2A12
194005	L612 EBV transformed B-cell
194012	EBV-transformed B cell
194044	B3
194109	lymphocyte
194127	hybridoma JB21
194130	hybridoma RAY4
194135	hybridoma JB32
194138	hybridoma 16M3C8
194205	BM-16
194212	Dauidi
194217	F4
194219	MB-19
194286	BM-18
194295	Ann2
194303	B20
194308	B9601
194312	MF8
194318	C304
194331	s5A9
194335	s5B7
194338	s6A3
194341	s6BG8
194344	s6C9
194347	s6G4
194375	8B3
194380	37GRK
194412	EBV-transformed
194416	418.F63.35
194446	316
194449	E51
194451	BD10
194462	4B4
194465	ITC88
194860	B21
194960	homopoietic TF-1
195098	032891
195106	Tera-2, U937, HL-60
195119	TE-89 osteosarcoma
195175	J5
195239	F6-2
195247	peripheral blood T cell
195263	JM101
195370	S3 (ATTC)
195375	Hela S3 (ATTC)
195412	A-172
195440	341-72
195467	BS2
195637	T CELL
195839	DT
195867	Nt2D1
195889	NCC-IT
195962	Kelly
195968	H3347
195974	RSA-ND
195981	acute promyelocytic leukemia cell lines HL-60
196010	keratinocytes
196078	IMR-90 leukemic
196291	LH114
196298	LH92
196338	MP-1
196446	DU145, LNCaP, PC3
196576	SP-49
196592	RPMI 1788
196601	T cell hybridoma (AC5-8)
196629	Daudi/Molt4
196655	SUP-T8
196672	HL-60 3c5I
196696	II-23.D7 cells stimulated with PMA for 4 hr
196746	mAb105 producing hybridoma cell
196750	mAb107 producing hybridoma cell
196769	mAb52 producing hybridoma cell
196773	mAb53 producing hybridoma cell
196777	mAb55 producing hybridoma cell
196781	mAb56 producing hybridoma cell
196785	mAb57 producing hybridoma cell
196789	mAb58 producing hybridoma cell
196793	mAb59 producing hybridoma cell
196947	WI26 VA4
196966	M73
196978	RPMI1788(EB virus-transformed B-cell line)
196990	HS913T
196998	184 (from M. Stampfer)
197100	Manca
197194	ML-1; U-931
197234	Mia-PaCA-2
197241	CEM-ON
197320	acute promyelocytic cell (ML3)
197362	U1-Mel
197391	retinal pigment epithelium (0041 from M. Del
197419	Human Lopez natural killer cell leukemia
197552	GM03560
197600	RC654. EBV transformed
197608	B lymphoblastoid HPB-MLT
197616	KRC033
197622	SHJO; 32/37; KRC032
197628	Bristol 8
197632	GRC138
197637	GRC138; JY
197651	AP630 EBV-transformed B cell line
197666	RSA (EBV transformed B cell line)
197670	CALOGERO (#9084)
197687	EBV transformed KY
197711	MLH (EBV transformed B cell line)
197714	KRC103
197718	EVB transformed B cell line
197722	krc103
197729	GRC212
197772	EBV-transformed LCL
197831	19148
197877	Epstein-Barr transformed B cell line DBB
197895	Epstein-Barr virus transformed lymphoblastoid
197919	373
197928	Hmy2 and C1R
197933	AP
197938	LWAGS
197941	2627 American Indian Tribe
197948	DAN723
197953	LEE743
197971	IMR-90, U373 (in part)
197980	IFN-gamma-induced U937
197987	THAI742
198015	GRC 150
198019	KRC 110
198059	LLICRF
198073	HLA-homozygous B
198080	VAVY, RSH,BH, DBB
198101	2012
198107	KAS116
198111	EMJ
198114	KAS011
198117	E418 1324
198120	Ek
198123	MOU
198126	BOLETH
198129	DKB, YT
198132	SPACH
198135	VAVY
198138	BM16
198185	DkB
198200	AMAI
198233	Vavy
198239	EK
198244	E4181324
198247	BH
198260	2013
198291	2708
198333	HMy2.A3m
198358	HMy2.DRN
198445	DR4
198507	1125
198512	AMALA(10w9064)
198515	CB6B(10w9064)
198537	EBC transformed B cell line SS713
198555	EBV-transformed 3104 B cell line
198577	RPMI 8402
198633	T-CEMB
198748	SP-49, KOCL-33, KOCL-45
198756	RS4;11
198786	U937/Dyl
198805	PMN
198811	MO6
198817	HL 60
198862	HPC-Y5
198896	MDA-MB-468
199118	BT20
199157	TIG-1-20
199178	stratagene E. coli XL1-blue
199187	IFN-alpha-2 treated cell line T98G
199210	COLO320
199223	promyelocytic leukemia cell line HL60
199228	promyelocytic leukemia cell line HL-60
199241	IFIO-D3
199512	HLC-1
199583	rhabdomyosarcoma
199646	VA13
199672	Nalm6 pre-B cell and RIC2 retinal cell
199679	MCH 200.3
199768	WI26-VA4
199775	namalwa
199784	A875
199815	jurkat T-lymphocytes
199924	B22
199932	PCR IM9 lymphocyte
199941	EBV-transformed B cell line RPMI 8866
200067	U937, cAMP induced
200187	GLC-1
200199	BS6
200229	U
200293	TYKnuR
200323	Jurkai
201000	platelet
201013	human breast carcinoma MCF-7; human lung
201084	H647
201098	HL60 (promyelocytic leukemia cell)
201249	EoL-1 (butyrate-stimulated)
201328	Capan-2
201335	HPAF-CD11
201411	CAKI-2
201425	Jurkat/Swei
201440	-
201647	AG 1518
201662	SK5
201677	Tera 2
201818	YTN-10
201968	blood platelet cell line HEL
202129	leukemia K562
202364	HuT-14
203018	NK3.3, natural killer-like cell line
203077	IM-9-P derived from IM-9
203116	AMA
203213	HEp-2
203313	MGC 1
203488	LNCaP-ATCC
203653	Daudi Burkitt's lymphoma cell line
203707	KU812E
203777	Meg-01, human platelets
203860	G401
204017	EBV-immortalized peripheral B-lymphocyte
204025	EBV-transformed peripheral B-cell line and
204049	SK-Hep-1
204158	retinoblastoma cell line Y79, and normal
204168	SCLC-SA
204178	BOY
204187	NALM 6
204214	G-401 (ATCC CRL 1441)
204285	0041
204294	NF1002
204384	A101D
204440	PA-1, teratocarcinoma
204469	D98/AH-2
204914	OXEN
205202	Eahy926 and HUVEC
205237	SW620
205243	HT29 cl-CIII
205325	HL1011B
205449	CCF-STTG1
205522	FLEB14-14
205755	human erytholeukemia (HEL)
205873	AML-193
205880	HPB-ALL ; CEM
205988	FS11
206033	Molt13
206175	T98G, CCF-STTG1, U87MG
206259	HOB1/VCR1.0
206275	manca
206323	5C10
206344	HUVE
206505	KB cells
206540	human hepatoma cell line KYN-1
206564	CCRF-HSB-2
206585	MOLT-4 cl. 8
206598	EBV transformed
206601	EBV transformed cell line
206606	LBUF
206617	Hut-78
206686	MOLT 4 clone 8
206692	LG37
206706	Tcc UA-S2
206934	JM
207463	TcHST2
207492	neutrophyl
207523	102DRF, 139DRD AND 2DLE (CTL CLONES)
207541	CTL 2DLE
207548	CTL 21S69
207550	CTL 27S69
207552	CTL 29S15
207554	CTL 2SRZ
207558	CTL 31GRK
207560	CTL 33.8S15
207562	CTL 33S69
207564	CTL 3SRF
207566	CTL 47S69
207570	CTL 58GRK
207572	CTL 74GRK
207574	CTL 74GRKB
207576	CTL 7S15
207578	CTL 93S15
207582	CTL 116.8GRK
207759	CTL 139DRD
207788	CTL 22DAG
207825	CTL 140
207877	AL4.1
207883	CTL 122GRK
207888	CTL 100GRK
207891	CTL 11.8SLG
207894	CTL 11SRY, CTL 40SRY
207909	CTLs 12SRF, 12SLG, 60SLG, 4S15, 11S15, 37SLG
207911	CTL 13SLG
207936	CTL 13SRC
207939	CTL 20.8GRK
207958	CTL 168DRF
207965	CTL 29s15
208036	CTL 58GRK, CTL 20.8 GRK
208043	GM2.11
208049	CTL 116GRK
208052	CTL 11SRY
208060	CTL 12SRF
208146	D38
208323	DS6
208335	KT2
208641	short ragweed pollen allergen-specific T-cell
208659	TcSSTW
209011	AL61.102
209082	W138
209119	Tera-2
209294	1027 F57
209680	UC/HeLa2-5
209751	HepG2, HeLa
209838	SPL
209950	GF-D8
210142	HMV-II melanoma
210148	A2058
210269	YT2C2
210307	M28 somatic cell hybrid
210327	MeWo melanoma DNA, and cDNA to mRNA
210359	U-105MG
210551	ECV-304
210598	HSB-2
210613	VS C64.03
210622	4-1D4
210629	46JVM-A11
210636	AY29
210643	14MT-B3
210648	VS F41.03
210654	14MT-C5
210665	46JVM-A1
210671	341-44
210687	14MT-D1
210701	B5.62
210711	AY51
210718	4-1A7
210724	AY7
210729	VS F55.03
210739	4-1A8
210743	AY28
210772	5E1
211071	CRL-1262
211119	IMR91 and CF150-6
211127	IMR90
211386	lymphoblastoid transformed cell line
214358	M426, WI38
215796	TC106 EBV transformed B cell line
215827	GM3299; GM637
215886	3T3-VMCUB2-1
216189	CEM C7
216229	A375
217305	Ble
219194	TTC466
219198	TTC633
219752	i37-4
219803	MC4100E3
219822	TIL A42
219878	RPMI1788
219979	pre-acute lymphocytic leukemia (pre-ALP)
220012	Jurkat J6
220209	CB STL-1 hybridoma
220313	hybridoma AEE111F
220623	RF1; RF48
222510	adenovirus transformed retinal cells, Nalm-6
222535	Bjab
222819	differentiated HL-60 cell
222831	T cell clone
222844	T cell line
222876	b cell clone
222980	NCI-H157 NCI-H889
222984	NCI-H157
223044	HeLa S3 cell line
223106	FCCM-9
223116	EBV-transformed Korean B-cell line (K-KT)
4530039	WI-38 VA13
4530290	ECV 304
4530505	Panc-1
4530520	Panc 1
4530745	O-128
4535118	GES-1; MC
4541912	S3
4542855	fibrosarcoma HT1080
4543458	WCS
4546152	ML-1260
4546413	gingival fibroblasts IMR90
4546451	.220
4557808	NB4 cells
4558223	SW1353
4558688	A431, Hep3B, HT1080, T2, SW480, U378
4586776	NCI-H69
4594633	AsPC-1(ATCC:CRL-1682)
4599092	BT-325
4650199	4AF1/106/KO15
4788187	skov
4788248	AP20 melanoma
4788260	promyelocytic HL60 cell line
4788442	HBE-M
4788463	AGZY-83a
4788505	A549.A549
4788508	HSG
4788655	HT1080-6TGc5
4788707	LNCaP prostate cancer
4788709	E8CASS; variant of MCF7
4789040	OCI LY8-C3P; clonally related variant of
4789052	HNE1
4789064	u937
4789077	BE1
4789079	normalized K562
4789240	oc3-VGH
4789278	PC-3M high metastasis subline 1E8
4789280	PC-3M low metastasis subline 2B4
4789300	PC-3M subline IE8
4789326	PANC1
4789335	SKOV3; 3AO
4789386	BEAS-2B
4789426	EB1
4789814	HNE-1
4789837	CGL3
4789844	ATCC SW1088
4789852	ATCC HTB-12; SW1088
4789949	LoVo
4791235	SGC-7901
4959456	PMA-induced HL60 human leukemic cell line
5037843	T84 carcinoma cell line
5164922	Primary Culture of Peripheral Blood
5555574	Q1Z
5555887	HTori-3, control line
5555890	HTG9
5555893	HTG8
5555901	HTG13
5555911	HTA4
5555935	HTG2
5555949	HTLV-1 transformed T cell line C91-PL
5555989	HTLV-1 positive adult T-cell leukemia cell
5556017	adult T-cell leukemia cell line JuanaW
5556096	adult T-cell leukemia cell line JuaW
5652921	HeLa cell line; ATCC
5969637	KG1-a
6037780	THP-1 (TIB-202)
6038979	KB(ATCC CCL-17)
6040389	SK-Mel-28(ATCC HTB 72)
6186703	MGC3
6222687	melanoma microcell hybrid line, MelJuSo-28(1n
6222690	melanoma line, MelJuSo
6251438	MGC2
6252175	MGC4
6253047	MGC1
6299262	MGC85
6429512	MGC36
6429920	rhabdomyosarcoma (RD) cell line
6443280	Human Umbilical Vein Endothelial Cell
6671280	CAMA1Ee
6672783	HSC172 (60PDL)
6679066	KM12C(HCC)-parental human colon carcinoma
6679242	Human colon adenocarcinoma;ATCC HTB 37
6682278	KM12C(HCC)metastasis into mouse (liver)
6780857	Clonetics 4075
7059620	H9
7059634	adenocarcinoma
7073351	T84 (ATCC number CCL-248)
7580262	SHEE(Immortalized esophageal epithelial cell
7646530	H526
7646539	HBEC
7714467	H2170
8249106	NSTH II
8636880	myeloid leukemia HL-60
8637960	PCI-O6B
8637986	exocervical cells
8638109	23132 gastric carcinoma cell line
8638146	SK-ER3
8638246	primary cell culture
8638264	Clonetics Corp. (San Diego, CA) strain #68 and
8638300	KM3
8638460	melanoma UACC-903
8638502	GM-CSF-deprived TF-1 cell line
8638643	HS74 and its SV40-transformed sublines
8711100	K562 (erythro-leukemic)
8711323	T Lymphoblastoid cell line ATCC#CCL119